Industry News
Targeting cancer stem cells: results in phase I trial of OMP-54F28
Jun 03, 2014
At the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO), University of Colorado Cancer Center researchers reported results of a Phase I trial of OMP-54F28 (FZD8-Fc), an... Read More
Support of ibrutinib strengthened as second-line therapy for CLL by phase 3 study
Jun 03, 2014
In a head-to-head comparison of two Food and Drug Administration-approved drugs for the treatment of relapsed chronic lymphocytic leukemia (CLL), ibrutinib significantly outperformed ofatumumab as a... Read More
Volatile organic compounds in exhaled breath show presence and stage of lung cancer
Jun 03, 2014
Results of a University of Colorado Cancer Center study presented at the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO) show that a test of organic compounds in exhaled... Read More
New targetable form of disease revealed by responses with crizotinib in MET-amplified lung cancer
Jun 03, 2014
A study presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2014 reports the results of a first-in-human, phase 1 dose escalation trial of crizotinib (XALKORI) in 14 patients... Read More
Promising response to new combination therapy by patients with metastatic colon cancer
Jun 03, 2014
In an aggressive disease known for poor response rates, researchers from The University of Texas MD Anderson Cancer Center found patients with advanced colorectal cancer responded well to a... Read More
Discovery of possible basis for treating circadian clock disorders and associated metabolic problems
Jun 03, 2014
Structural biologists have made important progress towards better understanding the functioning of the circadian clock. Read More
Advanced bladder cancer patients benefit from immune therapy
Jun 03, 2014
A multi-center phase I study using an investigational drug for advanced bladder cancer patients who did not respond to other treatments has shown promising results in patients with certain tumor... Read More
It is estimated that there will be nearly 19 million cancer survivors in the U.S by 2024
Jun 03, 2014
The number of cancer survivors in the United States, currently estimated to be 14.5 million, will grow to almost 19 million by 2024, according to an updated report by the American Cancer Society. Read More
Potential dangers of chemotherapy regimen for bladder cancer patients uncovered by trial
Jun 03, 2014
Patients with muscle-invasive bladder cancer often benefit from chemotherapy before surgery to remove the tumor, but a test of one regimen by researchers at Fox Chase Cancer Center was halted when... Read More
New clinical guidelines for cancer-related fatigue
Jun 03, 2014
Fatigue is a debilitating problem for cancer patients undergoing treatment; however, it also poses a huge detriment after treatment and can significantly affect quality of life. Read More
Previous Page Next Page